A group of researchers from the Cleveland Clinic provided the electronic monitoring devices to a group of patients with COPD. The platform, from Madison, Wis.-based Propeller Health, connects a sensor to a patient’s existing COPD inhaler, which then collects and transmits data to provide patients with alerts and insights regarding medication adherence and usage.
After using the device, compared to the year prior to enrollment in the study, the patients experienced a significant reduction in COPD-related hospitalizations and ER visits: from an average of 3.4 hospital trips to 2.2.
“We prescribe inhaled medications for patients with COPD all the time. It’s really the cornerstone of their therapy, and when they return to the clinic we do ask them whether they’re using their medications, but the reality is we never know how adherent patients are objectively,” Umur Hatipoğlu, MD, a Cleveland Clinic pulmonologist, said. “Electronic inhaler monitoring allows us to assess inhaler adherence at the point of care.”
More articles about health IT:
Most health system CFOs lack agreeable cooperation with CIOs, survey finds
Google’s 5 latest health-related job openings
Vonage, Pulsara partner on mobile telehealth
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
